0000905148-17-000939.txt : 20171215
0000905148-17-000939.hdr.sgml : 20171215
20171215183849
ACCESSION NUMBER: 0000905148-17-000939
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171215
FILED AS OF DATE: 20171215
DATE AS OF CHANGE: 20171215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CPMG Inc
CENTRAL INDEX KEY: 0001372218
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 171260078
BUSINESS ADDRESS:
STREET 1: 2000 MCKINNEY
STREET 2: SUITE 2125
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: 214-871-6816
MAIL ADDRESS:
STREET 1: 2000 MCKINNEY
STREET 2: SUITE 2125
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
BUSINESS PHONE: 972-865-2206
MAIL ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
4
1
form4.xml
X0306
4
2017-12-15
0001358762
REATA PHARMACEUTICALS INC
RETA
0001372218
CPMG Inc
2000 MCKINNEY AVE., STE 2125
DALLAS
TX
75201
true
true
Class A common stock
2017-12-13
4
P
0
19982
24.8838
A
462542
I
By Gallopavo, LP
Class A common stock
2017-12-13
4
P
0
49
23.9767
A
462591
I
By Gallopavo, LP
Class A common stock
2017-12-14
4
P
0
14866
24.6528
A
477457
I
By Gallopavo, LP
Class A common stock
2017-12-13
4
P
0
31471
24.8838
A
728503
I
By Roadrunner Fund, LP
Class A common stock
2017-12-13
4
P
0
78
23.9767
A
728581
I
By Roadrunner Fund, LP
Class A common stock
2017-12-14
4
P
0
19672
24.6528
A
748253
I
By Roadrunner Fund, LP
Class A common stock
2017-12-13
4
P
0
9990
24.8838
A
96915
I
By Blackwell Partners LLC
Class A common stock
2017-12-13
4
P
0
25
23.9767
A
96940
I
By Blackwell Partners LLC
Class A common stock
2017-12-14
4
P
0
6245
24.6528
A
103185
I
By Blackwell Partners LLC
Class A common stock
2017-12-13
4
P
0
59982
24.8838
A
393515
I
By Yellow Warbler, LP
Class A common stock
2017-12-13
4
P
0
148
23.9767
A
393663
I
By Yellow Warbler, LP
Class A common stock
2017-12-14
4
P
0
37492
24.6528
A
431155
I
By Yellow Warbler, LP
Class A common stock
110640
I
By Killdeer Fund, LP
Class A common stock
109415
I
By Mallard Fund, LP
Class A common stock
280500
I
By Willet Fund, LP
Class A common stock
37909
I
By Crested Crane, LP
Class A common stock
63481
I
By Flamingo Fund, LP
Class A common stock
334740
I
By Sandpiper Fund, LP
Class A common stock
160265
I
By Kestrel Fund, LP
Class A common stock
11076
I
By CD Fund, LP
Class A common stock
134
I
By Redbird Life Sciences Partners, LP
Class A common stock
113
D
Class B Common Stock
Class A Common Stock
150186
150186
I
By Mallard Fund, LP
Class B Common Stock
Class A Common Stock
307776
307776
I
By Kestrel Fund, LP
Class B Common Stock
Class A Common Stock
123379
123379
I
By CD Fund, LP
Class B Common Stock
Class A Common Stock
1490
1490
I
By Redbird Life Sciences Partners, LP
Class B Common Stock
Class A Common Stock
1251
1251
D
This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $24.08 to $25.08 inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $23.97 to $23.99 inclusive.
This price reflects the weighted average purchase price for open-market purchases on December 14, 2017, within a $1.00 range. The actual prices for these transactions range from $24.40 to $24.92, inclusive.
These shares of Class B common stock are convertible into Class A common stock on a one-for-one basis at the holder's election at any time for no additional consideration, and have no expiration date.
The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Mr. McGaughy, Jr., a co-director and co-shareholder of the Reporting Person, serves on the Issuer's Board of Directors (the "Board") as a representative of the Reporting Person. By virtue of his representation on the Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person is deemed to be a director by deputization.
/s/ John Bateman, Chief Operating Officer of CPMG, Inc.
2017-12-15